Nanovibronix, Inc. (NASDAQ:FEED) Sees Significant Growth in Short Interest

Nanovibronix, Inc. (NASDAQ:FEED) saw a large increase in short interest in the month of August. As of August 14th, there was short interest totaling 344,075 shares, an increase of 359.0% from the July 30th total of 74,962 shares. Currently, 3.5% of the shares of the stock are sold short. Based on an average trading volume of 3,043,455 shares, the short-interest ratio is presently 0.1 days.

Insider Activity

In other news, insider Christian Michael Glibert sold 210,000 shares of the stock in a transaction that occurred on Monday, June 22nd. The shares were sold at an average price of $0.69, for a total value of $144,900.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 12.20% of the stock is owned by company insiders.

Nanovibronix Price Performance

Shares of FEED traded down $0.01 during mid-day trading on Thursday, hitting $0.37. The company’s stock had a trading volume of 86,367 shares, compared to its average volume of 1,627,032. The firm has a 50-day moving average price of $0.45 and a 200 day moving average price of $1.20. The stock has a market capitalization of $4.08 million, a price-to-earnings ratio of -0.04 and a beta of 1.38. Nanovibronix has a fifty-two week low of $0.29 and a fifty-two week high of $17.40.

Nanovibronix (NASDAQ:FEED) last released its earnings results on Monday, August 17th. The company reported ($1.98) EPS for the quarter. The business had revenue of $0.24 million for the quarter. Nanovibronix had a negative net margin of 1,093.61% and a negative return on equity of 60.73%.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on FEED shares. Weiss Ratings restated a “sell (e+)” rating on shares of Nanovibronix in a research report on Tuesday, July 21st. Wall Street Zen raised Nanovibronix from a “strong sell” rating to a “sell” rating in a research note on Sunday, July 12th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Nanovibronix presently has an average rating of “Sell”.

About Nanovibronix

Nanovibronix (NASDAQ: FEED) is a medical device company focused on the development and commercialization of non?invasive therapeutic ultrasound technologies for clinical and consumer healthcare applications. The company’s product portfolio centers on wearable ultrasound devices designed to deliver low?intensity acoustic energy to soft tissue with the objective of promoting wound healing and reducing pain. Nanovibronix positions its technology as an alternative or adjunct to conventional wound?care and analgesic therapies, aiming to address chronic and acute conditions that are managed in both outpatient and home settings.

The company concentrates its commercial efforts on supplying hospitals, wound?care clinics, long?term care facilities and patients requiring home?based therapies.